Skip to main content

Table 3 Association between subjects with lung invovlement and the presence of other pulmonary complications within 2 years of follow-up, adjusted for age and gender

From: Lung involvement at presentation predicts disease activity and permanent organ damage at 6, 12 and 24 months follow - up in ANCA - associated vasculitis

Pulmonary complications

OR (95% CI)

P-value

Pulmonary hypertension

1.21 (0.92, 1.28)

0.082

Pulmonary fibrosis

1.79 (1.48, 2.12)

<0.001

Pulmonary infarction

0.99 (0.91, 1.11)

0.222

Pleural fibrosis

1.13 (0.94, 1.21)

0.138

Chronic asthma

1.27 (1.12, 1.38)

0.072

FEV1/FVC ratio*

1.42 (1.27, 1.84)

0.045

DLCO/VA**

1.31 (1.22, 1.76)

0.045

  1. *Ratio of forced expiratory volume in one second (FEV1) to force vital capacity (FVC).
  2. **Ratio of diffusing capacity of the lung for carbon monoxide (DLCO) to alveolar volume (VA).
Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us